why choose us

First received: July 10, 2023

Clinical Trial: Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lymphoblastic Leukemia

Study Type: INTERVENTIONAL


Official Title: Phase 1b Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia

Brief Summary: To assess the feasibility of oral dasatinib pulses (3 consecutive days per week) during the first month following infusion of brexucabtagene autoleucel (Tecartus) in adults with relapsed or refractory B-cell acute lymphoblastic leukemia.

Read more